Literature DB >> 21688382

Treatment of recurrent hepatocellular carcinoma after liver transplantation.

Eric Davis1, Russell Wiesner, Juan Valdecasas, Yoshiaki Kita, Massimo Rossi, Myron Schwartz.   

Abstract

Entities:  

Mesh：

Year:  2011        PMID： 21688382     DOI： 10.1002/lt.22361

Source DB:  PubMed          Journal:  Liver Transpl        ISSN： 1527-6465            Impact factor:   5.799


× No keyword cloud information.
  14 in total

1.  Role of operative therapy in non-cirrhotic patients with metastatic hepatocellular carcinoma.

Authors:  Victor Zaydfudim; Rory L Smoot; Clancy J Clark; Michael L Kendrick; Florencia G Que; Michael B Farnell; David M Nagorney
Journal:  J Gastrointest Surg       Date:  2012-05-30       Impact factor: 3.452

Review 2.  Managements of recurrent hepatocellular carcinoma after liver transplantation: A systematic review.

Authors:  Nicola de'Angelis; Filippo Landi; Maria Clotilde Carra; Daniel Azoulay
Journal:  World J Gastroenterol       Date:  2015-10-21       Impact factor: 5.742

Review 3.  Liver transplantation for advanced hepatocellular carcinoma: how far can we go?

Authors:  Kyung-Suk Suh; Hae Won Lee
Journal:  Hepat Oncol       Date:  2015-01-12

4.  Recommendations for liver transplantation for hepatocellular carcinoma: an international consensus conference report.

Authors:  Pierre-Alain Clavien; Mickael Lesurtel; Patrick M M Bossuyt; Gregory J Gores; Bernard Langer; Arnaud Perrier
Journal:  Lancet Oncol       Date:  2011-10-31       Impact factor: 41.316

Review 5.  Different Models to Predict the Risk of Recurrent Hepatocellular Carcinoma in the Setting of Liver Transplantation.

Authors:  Helena Degroote; Anja Geerts; Xavier Verhelst; Hans Van Vlierberghe
Journal:  Cancers (Basel)       Date:  2022-06-16       Impact factor: 6.575

Review 6.  Liver transplantation for hepatocellular carcinoma: outcomes and novel surgical approaches.

Authors:  Gonzalo Sapisochin; Jordi Bruix
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2017-01-05       Impact factor: 46.802

7.  Therapeutic Efficacy of Sorafenib in Patients with Hepatocellular Carcinoma Recurrence After Liver Transplantation: A Systematic Review and Meta-Analysis.

Authors:  Zhao Li; Jie Gao; ShengMin Zheng; Yang Wang; Xiao Xiang; Qian Cheng; Jiye Zhu
Journal:  Turk J Gastroenterol       Date:  2021-01       Impact factor: 1.852

8.  Factors predicting survival after post-transplant hepatocellular carcinoma recurrence.

Authors:  Christian Toso; Sonia Cader; Ariane Mentha-Dugerdil; Glenda Meeberg; Pietro Majno; Isabelle Morard; Emiliano Giostra; Thierry Berney; Philippe Morel; Gilles Mentha; Norman M Kneteman
Journal:  J Hepatobiliary Pancreat Sci       Date:  2013-03       Impact factor: 7.027

9.  Does liver resection/transplantation affect respiratory induced liver motion in patients with hepatocellular carcinoma?

Authors:  Yong Hu; Yong-Kang Zhou; Yi-Xing Chen; Lu-Xi Ye; Zhao-Chong Zeng
Journal:  J Appl Clin Med Phys       Date:  2017-06-06       Impact factor: 2.102

10.  Synergistic effect of metformin on sorafenib in in vitro study using hepatocellular carcinoma cell lines.

Authors:  Yong-Gyu Chung; Eunyoung Tak; Shin Hwang; Joo-Young Lee; Ji-Ye Kim; Ye-Young Kim; Gi-Won Song; Kyoung-Jin Lee; Nayoung Kim
Journal:  Ann Hepatobiliary Pancreat Surg       Date:  2018-08-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.